# Melt Pharmaceuticals, Inc. — Form D/A

Melt Pharmaceuticals, Inc. of SAN DIEGO, CA, a company, filed a Form D amendment with the SEC on 2024-04-08. The offering totals $47.8M, of which $42.3M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2024-04-08
- Form: D/A
- Accession: 0001767398-24-000004
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $47.8M
- Amount sold: $42.3M
- Remaining: $5.5M
- Investors: 309
- Date of first sale: 2023-07-28
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-489452

## Issuer

- Name: Melt Pharmaceuticals, Inc.
- CIK: 0001767398
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 12264 EL CAMINO REAL, SUITE 350 12264 El Camino Real, Suite 350, SAN DIEGO, CA, 92130
- Phone: 8587044042

## Officers, directors & promoters (13)

| Name | Role | Location |
| --- | --- | --- |
| Larry Dillaha | Director | San Diego, CA |
| Larry Dillaha | Executive Officer | San Diego, CA |
| Brad Osborne | Executive Officer | Cottage Grove, WI |
| John Berdahl | Director | San Diego, CA |
| John Berdahl | Related Person | San Diego, CA |
| Larry Dillaha | Related Person | San Diego, CA |
| Mark Baum | Director | San Diego, CA |
| Mark Baum | Related Person | San Diego, CA |
| Andrew Boll | Director | San Diego, CA |
| Andrew Boll | Related Person | San Diego, CA |
| Gregory Madison | Director | San Diego, CA |
| Gregory Madison | Executive Officer | San Diego, CA |
| Gregory Madison | Related Person | San Diego, CA |

## Other filings by this issuer (10)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2024-03-11](https://search.stillhousedata.com/formd/0001767398-24-000003) | D/A | $47.8M | $41.6M |
| [2024-02-12](https://search.stillhousedata.com/formd/0001767398-24-000002) | D/A | $47.8M | $39.5M |
| [2024-01-09](https://search.stillhousedata.com/formd/0001767398-24-000001) | D/A | $47.8M | $39.0M |
| [2023-12-11](https://search.stillhousedata.com/formd/0001767398-23-000006) | D/A | $30.0M | $20.2M |
| [2023-11-13](https://search.stillhousedata.com/formd/0001767398-23-000005) | D/A | $30.0M | $19.6M |
| [2023-10-13](https://search.stillhousedata.com/formd/0001767398-23-000004) | D/A | $30.0M | $17.1M |
| [2023-09-12](https://search.stillhousedata.com/formd/0001767398-23-000002) | D/A | $30.0M | $10.6M |
| [2023-08-11](https://search.stillhousedata.com/formd/0001767398-23-000001) | D | $30.0M | $1.8M |
| [2019-04-05](https://search.stillhousedata.com/formd/0001767398-19-000002) | D/A | $25.8M | $11.4M |
| [2019-02-13](https://search.stillhousedata.com/formd/0001767398-19-000001) | D | $25.8M | $10.8M |

## More

- [CIK 1767398 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1767398&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001767398-24-000004.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.